Latest Updates
|
February 2010 Marketed Drug
Updates and Additions
|
Brand Name
|
Generic Name
|
Other Designation
|
Vectibix |
Panitumumab |
ABX-EGF (formerly known as clone E7.6.3) |
Trellasar, De-Capeptyl (UK), Trelstar LA (USA), Trelstar Depot (USA), Decapeptyl (Europe), Pamorelin (Germany) |
Triptorelin pamoate |
D-TRP-6-LHRH, Debio 8206 |
D-TRP-6-LHRH, Debio 8206 |
Catumaxomab |
|
Hycamtin, Hycaptamine |
Topotecan |
NSC-609699, SK&F-104864 |
Tykerb (USA, EU), Tyverb |
Lapatinib ditosylate |
572016, GW572016, GW 572016, GSK 572016 |
Arzerra |
Ofatumumab |
HuMax-CD20, GSK1841157 |
Gardasil, Silgard (Eastern Europe) |
Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine |
|
Proleukin |
Aldesleukin (IL-2) |
NSC-373364 |
|
|
WF10 |
Tarceva |
Erlotinib |
CP 358774, OSI-774, R1415, RG1415, NSC 718781 |
Celebrex (formerly known as Celebra) |
Celecoxib |
SC-236, SC-58635 |
Nikidess, Aromasin |
Exemestane |
FCE 24304 |
Sutent |
Sunitinib malate |
SU011248, SU11248, SU-11248 |
Glutoxim (Russia) |
|
BAM-002, NOV-002 (USA) |
|
NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE: 1-949-830-0448 FAX: 1-949-830-0887
INFO@NEWMEDINC.COM
|